Brief: InMed Pharmaceuticals Says On September 19, Received Written Notice From The Listing Qualifications Department Staff Of The Nasdaq Capital Market
25/09/2023 11:12
Sept 25 (Reuters) - InMed Pharmaceuticals Inc INM.O :
* INMED PHARMACEUTICALS INC - ON SEPTEMBER 19, RECEIVED
WRITTEN
NOTICE FROM THE LISTING QUALIFICATIONS DEPARTMENT STAFF OF THE
NASDAQ CAPITAL MARKET
* INMED PHARMACEUTICALS INC - NOTICE FROM NASDAQ NOTIFYING
FAILURE
TO SATISFY A CONTINUED LISTING RULE OR STANDARD
Further company coverage: INM.O
((Reuters.Briefs@thomsonreuters.com;))